These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25556489)

  • 21. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
    Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-1180 promoted the proliferation of hepatocellular carcinoma cells by repressing TNIP2 expression.
    Zhou X; Zhu HQ; Ma CQ; Li HG; Liu FF; Chang H; Lu J
    Biomed Pharmacother; 2016 Apr; 79():315-20. PubMed ID: 27044843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
    World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WNT1 Gene from WNT Signaling Pathway Is a Direct Target of miR-122 in Hepatocellular Carcinoma.
    Ahsani Z; Mohammadi-Yeganeh S; Kia V; Karimkhanloo H; Zarghami N; Paryan M
    Appl Biochem Biotechnol; 2017 Mar; 181(3):884-897. PubMed ID: 27687586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR‑144‑3p regulates the resistance of lung cancer to cisplatin by targeting Nrf2.
    Yin Y; Liu H; Xu J; Shi D; Zhai L; Liu B; Wang L; Liu G; Qin J
    Oncol Rep; 2018 Dec; 40(6):3479-3488. PubMed ID: 30542710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of miR-138 Increases Sensitivity to Cisplatin in Hepatocellular Carcinoma by Regulating EZH2.
    Zeng T; Luo L; Huang Y; Ye X; Lin J
    Biomed Res Int; 2021; 2021():6665918. PubMed ID: 33748276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73.
    Zhao J; Xu T; Wang F; Cai W; Chen L
    Biomed Pharmacother; 2017 Jun; 90():744-751. PubMed ID: 28419971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-429 regulates the metastasis and EMT of HCC cells through targeting RAB23.
    Xue H; Tian GY
    Arch Biochem Biophys; 2018 Jan; 637():48-55. PubMed ID: 29191386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-21-5p Suppressed the Sensitivity of Hepatocellular Carcinoma Cells to Cisplatin by Targeting FASLG.
    Chen S; Yang C; Sun C; Sun Y; Yang Z; Cheng S; Zhuge B
    DNA Cell Biol; 2019 Aug; 38(8):865-873. PubMed ID: 31225740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-613 inhibits liver cancer stem cell expansion by regulating SOX9 pathway.
    Li B; Liu D; Yang P; Li HY; Wang D
    Gene; 2019 Jul; 707():78-85. PubMed ID: 31075412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
    Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-592 targets DEK oncogene and suppresses cell growth in the hepatocellular carcinoma cell line HepG2.
    Li X; Zhang W; Zhou L; Yue D; Su X
    Int J Clin Exp Pathol; 2015; 8(10):12455-63. PubMed ID: 26722432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulated miR-28-5p in human hepatocellular carcinoma correlated with tumor proliferation and migration by targeting insulin-like growth factor-1 (IGF-1).
    Shi X; Teng F
    Mol Cell Biochem; 2015 Oct; 408(1-2):283-93. PubMed ID: 26160280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulatory role of miR-211-5p in hepatocellular carcinoma metastasis by targeting ZEB2.
    Jiang G; Wen L; Deng W; Jian Z; Zheng H
    Biomed Pharmacother; 2017 Jun; 90():806-812. PubMed ID: 28437884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-505 enhances doxorubicin-induced cytotoxicity in hepatocellular carcinoma through repressing the Akt pathway by directly targeting HMGB1.
    Lu L; Zhang D; Xu Y; Bai G; Lv Y; Liang J
    Biomed Pharmacother; 2018 Aug; 104():613-621. PubMed ID: 29803174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
    Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
    Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway.
    Zhao L; Zhang Y
    Biochem Biophys Res Commun; 2015 Feb; 457(3):370-7. PubMed ID: 25580008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
    Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
    J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of
    Liu Z; Dang C; Xing E; Zhao M; Shi L; Sun J
    DNA Cell Biol; 2019 Nov; 38(11):1366-1373. PubMed ID: 31633393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [miR-129-1-3p reverses cisplatin resistance of HNE1/CDDP human nasopharyngeal carcinoma cells by targeting inhibition of WEE1 kinase].
    Zhang H; Lu J; Jiang C; Lu W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):1014-1019. PubMed ID: 31878998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.